T
TriSalus Life Sciences Inc. (TLSI)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
$2.29
+0.02 (+1.10%)
Market Cap: $140.06M
Last updated: Nov 17, 2026 at 4:26 PM ET
TriSalus Life Sciences Inc. (TLSI) Valuation Multiples
TriSalus Life Sciences (TLSI) trades at 2.9x sales and 198.8x book value. Its P/S ranged from 0.8x in 2023 to 5.8x in 2025 across the 3 year ends with a P/S figure.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 2.9x |
| Price to book | 198.8x |
| PEG | N/A |
| FCF yield | -18.4% |
Valuation History
| Year end | Price | P/S |
|---|---|---|
| 2025 | $6.98 | 5.8x |
| 2024 | $5.01 | 4.4x |
| 2023 | $8.45 | 0.8x |
Frequently Asked Questions About TLSI
What is TLSI's price to sales ratio?
TriSalus Life Sciences has a price to sales ratio of 2.9x.
TLSI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors